drugset / Trial / NCT05746377

Metoclopramide in Upper Gastrointestinal Bleed

NCT05746377

Phase 4 Unknown 60 enrolled Mercy Health System
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to test if metoclopramide can improve effectiveness of endoscopic intervention in upper gastrointestinal (GI) bleeds. The main questions the investigators hope to answer is Does metoclopramide lessen the need for repeat endoscopy, interventional radiology intervention or surgery in cases of upper GI bleed? Does metoclopramide improve visibility of the GI walls in cases of upper GI bleed?

Timeline

Start
2023-05-20
Primary completion
2024-02
Completion
2024-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Metoclopramide Small molecule 10 mg Intravenous